RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Kidney Reperfusion Injury
Accession: DOID:9006223
browse the term
Definition: Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the kidney, including swelling; hemorrhage; necrosis; and damage from free radicals.
Synonyms: exact_synonym: Kidney Ischemia-Reperfusion Injury; Renal Ischemia-Reperfusion Injury; Renal Reperfusion Injury
G
Ace
angiotensin I converting enzyme
IMP
RGD
PMID:21680852
RGD:6893484
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
IEP
mRNA:decreased expression:kidney
RGD
PMID:20528771
RGD:9685432
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acta1
actin, alpha 1, skeletal muscle
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
G
Acvr2b
activin A receptor type 2B
treatment
ISO
human construct in rat model
RGD
PMID:27732750
RGD:329322881
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Adam17
ADAM metallopeptidase domain 17
treatment
IEP
RGD
PMID:22015440
RGD:13703100
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Adam2
ADAM metallopeptidase domain 2
IEP
RGD
PMID:11967014
RGD:10047130
NCBI chr15:40,242,651...40,284,025
Ensembl chr15:40,242,783...40,283,952
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
RGD
PMID:18272597
RGD:9684850
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
ISO
RGD
PMID:21412771
RGD:8695946
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
treatment
IEP ISO
protein:increased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Akr1a1
aldo-keto reductase family 1 member A1
ISO
RGD
PMID:31089212
RGD:27226686
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
RGD
PMID:22022451
RGD:7241603
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Anxa1
annexin A1
treatment
IDA
RGD
PMID:20953576
RGD:7421585
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa5
annexin A5
ISO
RGD
PMID:21918686
RGD:7242028
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IEP
RGD
PMID:26362957
RGD:13703110
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apoa1
apolipoprotein A1
treatment
ISO
RGD
PMID:18535924
RGD:7241574
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Atm
ATM serine/threonine kinase
IEP
protein:increased expression:kidney
RGD
PMID:22768306
RGD:10053607
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:23151253
RGD:10054101
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:18221257 PMID:29285062
RGD:2293026 , RGD:13792599
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdkrb1
bradykinin receptor B1
ISO
RGD
PMID:18725957
RGD:7241559
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:26412257
RGD:11561958
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bmi1
BMI1 proto-oncogene, polycomb ring finger
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
G
Bnip3
BCL2 interacting protein 3
IEP
mRNA, protein:increased expression:kidney
RGD
PMID:23698117
RGD:11561968
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
C3
complement C3
treatment
IEP
RGD
PMID:19691975
RGD:7411689
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Calca
calcitonin-related polypeptide alpha
IMP
RGD
PMID:19194162
RGD:7204479
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:23151253
RGD:10054101
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
IEP
RGD
PMID:17596683
RGD:5684536
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Ccl11
C-C motif chemokine ligand 11
treatment
ISO
RGD
PMID:22160777
RGD:7247742
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
treatment ameliorates
ISO IDA
mRNA, protein:increased expression:kidney, lung, serum
RGD
PMID:24920753 PMID:20396927 PMID:18650485
RGD:329845564 , RGD:4891433 , RGD:11526113
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccn1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Cd14
CD14 molecule
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:10966493
RGD:7204444
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd40
CD40 molecule
treatment
IMP
RGD
PMID:25993320
RGD:11251055
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cfb
complement factor B
ISO
RGD
PMID:16467447 PMID:12538716
RGD:7242709 , RGD:7242734
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cfh
complement factor H
treatment
IEP ISO
protein:decreased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Ciita
class II, major histocompatibility complex, transactivator
ISO
RGD
PMID:14569092
RGD:7242896
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Cited1
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162
G
Col1a1
collagen type I alpha 1 chain
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col3a1
collagen type III alpha 1 chain
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Csf1
colony stimulating factor 1
ISO
mRNA:increased expression:kidney
RGD
PMID:23143303 PMID:19196448
RGD:7257565 , RGD:7257570
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf1r
colony stimulating factor 1 receptor
ISO
RGD
PMID:23143303
RGD:7257565
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:22189844 PMID:9407517
RGD:7204675 , RGD:7204727
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cxcl2
C-X-C motif chemokine ligand 2
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:20038794
RGD:7257679
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr4
C-X-C motif chemokine receptor 4
IEP
protein:increased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
treatment
IMP
RGD
PMID:23552495
RGD:7244372
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Daxx
death-domain associated protein
ISO
protein:increased expression:kidney:
RGD
PMID:18480747 PMID:18480747
RGD:9587836 , RGD:9587836
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
protein:increased expression:kidney (mouse)
RGD
PMID:31383731
RGD:151347540
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Dhfr
dihydrofolate reductase
treatment
IEP
mRNA,protein:decreased expression:kidney:
RGD
PMID:18408363
RGD:11040540
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Drd3
dopamine receptor D3
treatment
IDA
RGD
PMID:25989500
RGD:13506961
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Eed
embryonic ectoderm development
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974
G
Egln1
egl-9 family hypoxia-inducible factor 1
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
G
Egln3
egl-9 family hypoxia-inducible factor 3
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:16980042
RGD:10450580
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Eng
endoglin
IEP ISO
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:16751653 PMID:16751653
RGD:7248779 , RGD:7248779
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Ep300
E1A binding protein p300
IEP
protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:19961832 PMID:25581532
RGD:10401077 , RGD:11041698
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
F3
coagulation factor III, tissue factor
IEP
protein:decreased expression:lung
RGD
PMID:25883098
RGD:11341735
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fas
Fas cell surface death receptor
treatment
IEP
RGD
PMID:29285062
RGD:13792599
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:29285062
RGD:13792599
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr1a
Fc gamma receptor 1A
treatment
ISO
RGD
PMID:22402584
RGD:9685699
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fga
fibrinogen alpha chain
IEP
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
treatment
IEP ISO
mRNA, protein:increased expression:kidney
RGD
PMID:21685370 PMID:21685370
RGD:7175292 , RGD:7175292
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgfr2
fibroblast growth factor receptor 2
exacerbates ameliorates
ISO IMP
protein:increased phosphorylation:kidney (mouse)
RGD
PMID:20591940 PMID:32523960 PMID:29344510 PMID:22688984
RGD:155663667 , RGD:155782882 , RGD:155782904 , RGD:155882537
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Fgg
fibrinogen gamma chain
IEP
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Fn1
fibronectin 1
IEP
RGD
PMID:11352844
RGD:7205629
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
RGD
PMID:19095962
RGD:7242184
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gfer
growth factor, augmenter of liver regeneration
treatment
IEP ISO
protein:increased expression:kidney:
RGD
PMID:20332418 PMID:20332418
RGD:9685723 , RGD:9685723
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
G
Glo1
glyoxalase 1
IMP
RGD
PMID:19211689
RGD:7242566
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
G
Gpx3
glutathione peroxidase 3
IEP
protein:decreased expression:kidney mRNA:decreased expression:kidney
RGD
PMID:37033969 PMID:22442209
RGD:401827821 , RGD:401827906
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:24630969
RGD:10401866
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gstm1
glutathione S-transferase mu 1
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:29137244
RGD:158014894
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
IEP
protein:decreased expression:kidney
RGD
PMID:37033969
RGD:401827821
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
H2ax
H2A.X variant histone
treatment
IEP
RGD
PMID:23726287
RGD:8693706
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Has1
hyaluronan synthase 1
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
G
Has2
hyaluronan synthase 2
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
G
Havcr1
hepatitis A virus cellular receptor 1
IEP ISO
protein:increased expression:urine:
RGD
PMID:23552495 PMID:23085062 PMID:23019274
RGD:7244372 , RGD:7245489 , RGD:7245495
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment severity
IDA IMP
RGD
PMID:17519789 PMID:22432008
RGD:1626334 , RGD:9068883
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IMP
RGD
PMID:21291499
RGD:10755580
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsf1
heat shock transcription factor 1
IEP
protein:increased expression:kidney (rat)
RGD
PMID:23102208
RGD:10402775
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
RGD
PMID:7569112
RGD:7242788
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hyal1
hyaluronidase 1
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 8:108,250,668...108,254,519
Ensembl chr 8:108,250,667...108,260,210
G
Hyal2
hyaluronidase 2
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 8:108,241,895...108,246,853
Ensembl chr 8:108,243,133...108,246,850
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:28355607
RGD:14975115
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1r
insulin-like growth factor 1 receptor
IEP
mRNA: increased expression: kidney: 3 and 5 days post ischemia
RGD
PMID:10990448
RGD:7242905
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IMP
RGD
PMID:19546526
RGD:7495779
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
treatment
IDA ISO
RGD
PMID:24079335 PMID:28664613
RGD:7364864 , RGD:14975137
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il18
interleukin 18
treatment
IMP
RGD
PMID:22089199
RGD:8655971
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ameliorates
IDA ISO
RGD
PMID:20030532 PMID:24920753
RGD:7175501 , RGD:329845564
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
rat model treated with human protein mouse model treated with human protein
RGD
PMID:18363573 PMID:16849996 PMID:9555664
RGD:6907101 , RGD:6907359 , RGD:6909149
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhbb
inhibin subunit beta B
IEP
protein:increased expression:serum (rat)
RGD
PMID:27732750
RGD:329322881
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Itgb2
integrin subunit beta 2
ISO IMP
Associated with renal transplant patients
RGD
PMID:20504838 PMID:11007822
RGD:6907049 , RGD:6907073
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
IEP
protein:decreased expression:kidney
RGD
PMID:21250976
RGD:7297045
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Kl
Klotho
treatment
IEP ISO
mRNA,protein:decreased expression:renal tubule:
RGD
PMID:16204278 PMID:16204278
RGD:10403064 , RGD:10403064
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Kmt2a
lysine methyltransferase 2A
ISO
protein:increased expression:kidney (mouse)
RGD
PMID:31570196
RGD:155888490
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Lcn2
lipocalin 2
IEP ISO
protein:increased expression:urine: mRNA,protein:increased expression:kidney: mRNA,protein:increased expression:kidney,urine
RGD
PMID:23364806 PMID:23085062 PMID:20181666 PMID:27800610
RGD:7245469 , RGD:7245489 , RGD:126779563 , RGD:126790572
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lep
leptin
resistance
IDA
RGD
PMID:22969992
RGD:6909133
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals3
galectin 3
IEP
mRNA:increased expression:kidney
RGD
PMID:10980121
RGD:9685228
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
ISO IEP
RGD
PMID:20075199 PMID:26412257
RGD:11561916 , RGD:11561958
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IMP
RGD
PMID:23952292
RGD:10412647
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mc1r
melanocortin 1 receptor
IEP
protein:decreased expression:kidney outer medulla
RGD
PMID:18790174
RGD:5687322
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mir146a
microRNA 146a
treatment
IEP
RGD
PMID:27760486
RGD:155882556
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir320a
microRNA 320a
treatment
IEP
RGD
PMID:31089916 PMID:27760486
RGD:155882543 , RGD:155882556
NCBI chr15:45,516,392...45,516,473
Ensembl chr15:45,516,392...45,516,473
G
Mir381
microRNA 381
IEP
RNA:decreased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr 6:128,740,976...128,741,036
G
Mir423
microRNA 423
treatment
IMP
RGD
PMID:29137244
RGD:158014894
NCBI chr10:61,914,142...61,914,220
Ensembl chr10:61,914,133...61,914,226
G
Mir494
microRNA 494
ameliorates
ISO
RGD
PMID:23160513
RGD:155883172
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
G
Mpo
myeloperoxidase
IEP ISO
protein:increased activity:kidney
RGD
PMID:22950848 PMID:18055546
RGD:6909167 , RGD:7174699
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Muc1
mucin 1, cell surface associated
treatment
IDA
RGD
PMID:22019164
RGD:7245959
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Myc
MYC proto-oncogene, bHLH transcription factor
IEP
mRNA:increased expression:kidney (rat)
RGD
PMID:17220792
RGD:7207777
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
IEP ISO
RGD
PMID:24096033 PMID:22160772
RGD:13801197 , RGD:13801199
NCBI chr 1:243,408,656...243,413,715
Ensembl chr 1:243,408,619...243,413,817
G
Nes
nestin
IEP
RGD
PMID:24503548
RGD:11570523
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:31089916
RGD:155882543
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
treatment
IEP
RGD
PMID:18408363
RGD:11040540
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
treatment
IEP
RGD
PMID:29291552 PMID:18408363
RGD:13504682 , RGD:11040540
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox1
NADPH oxidase 1
treatment
IEP
RGD
PMID:34244746
RGD:329955363
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Nppa
natriuretic peptide A
ISO
RGD
PMID:20471588
RGD:7247717
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
RGD
PMID:21545725
RGD:11035217
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
severity
ISO
mRNA:increased expression:kidney
RGD
PMID:22343121 PMID:22343121
RGD:14700869 , RGD:14700869
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Ogg1
8-oxoguanine DNA glycosylase
IEP
RGD
PMID:12531391
RGD:2317150
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Pax2
paired box 2
IEP
mRNA, protein:increased expression:kidney
RGD
PMID:12444203
RGD:727468
NCBI chr 1:243,616,509...243,697,454
Ensembl chr 1:243,616,606...243,695,321
G
Pdgfb
platelet derived growth factor subunit B
IEP
mRNA,protein:increased expression:tubule, S3 segment:
RGD
PMID:10550325
RGD:8554477
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
IEP
mRNA:increased expression:kidney
RGD
PMID:10550325
RGD:8554477
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
IMP IEP
mRNA:increased expression:kidney
RGD
PMID:12819032 PMID:10550325
RGD:1580850 , RGD:8554477
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Peg10
paternally expressed 10
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:16778176
RGD:401851077
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
G
Pkd2
polycystin 2, transient receptor potential cation channel
IEP
protein:increased expression:kidney (rat)
RGD
PMID:12454224
RGD:1580868
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
IDA
RGD
PMID:24918615
RGD:10059636
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ptgis
prostaglandin I2 synthase
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:30413885
RGD:401959745
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Rnls
renalase, FAD-dependent amine oxidase
ISO
mRNA,protein:decreased expression:kidney,plasma:
RGD
PMID:23393318 PMID:23393318
RGD:7327166 , RGD:7327166
NCBI chr 1:231,037,481...231,309,855
Ensembl chr 1:231,037,486...231,309,823
G
Serpina1
serpin family A member 1
treatment
ISO
RGD
PMID:28235038
RGD:14695051
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Serpinc1
serpin family C member 1
severity
IMP
RGD
PMID:26108065 PMID:26108065
RGD:11354006 , RGD:11354006
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Serpinc1em2Mcwi
serpin family C member 1; ZFN induced mutant 2, Medical College of Wisconsin
IMP
RGD
PMID:26108065
RGD:11354006
G
Serpine1
serpin family E member 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Shh
sonic hedgehog signaling molecule
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:24744439
RGD:12859042
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Sirt1
sirtuin 1
treatment
IEP
RGD
PMID:22324445
RGD:9495930
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Six2
SIX homeobox 2
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 6:8,974,859...8,981,345
Ensembl chr 6:8,967,157...8,981,193
G
Slc22a1
solute carrier family 22 member 1
IEP
RGD
PMID:21835768
RGD:7243877
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
IEP
RGD
PMID:21835768
RGD:7243877
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc34a1
solute carrier family 34 member 1
IEP
protein:decreased expression:renal proximal tubule, brush border membrane (rat)
RGD
PMID:15775707
RGD:2311304
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
IEP
RGD
PMID:12819032
RGD:1580850
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Stat6
signal transducer and activator of transcription 6
severity
ISO
RGD
PMID:12709397
RGD:7244143
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:11796005
RGD:11062062
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tgfb1
transforming growth factor, beta 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
treatment severity
IDA ISO
RGD
PMID:23239000 PMID:23023072 PMID:22750071 PMID:20130923 PMID:11801667
RGD:7207892 , RGD:7207894 , RGD:7207896 , RGD:7240552 , RGD:7241087
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment
IDA ISO
RGD
PMID:23239000 PMID:20130923 PMID:11801667
RGD:7207892 , RGD:7240552 , RGD:7241087
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ameliorates
IEP ISO
protein:increased expression:serum
RGD
PMID:19925291 PMID:24920753
RGD:2315112 , RGD:329845564
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
mRNA:increased expression:lung
RGD
PMID:22728466
RGD:7245543
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Vcam1
vascular cell adhesion molecule 1
IEP
protein:increased expression:kidney
RGD
PMID:20164827
RGD:7240507
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vwf
von Willebrand factor
IEP
protein:increased expression:serum:
RGD
PMID:12684225
RGD:11080744
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wt1
WT1 transcription factor
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
G
Xdh
xanthine dehydrogenase
treatment
IMP
associated with Diabetes Mellitus, Type 2
RGD
PMID:22995295 PMID:20616412
RGD:7247637 , RGD:7247695
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Zfp667
zinc finger protein 667
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:67,601,803...67,622,041
Ensembl chr 1:67,601,807...67,622,041
G
Aco1
aconitase 1
IEP
RGD
PMID:20176611
RGD:11541086
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Alb
albumin
disease_progression
ISO
RGD
PMID:24370342
RGD:11035281
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:17298994
RGD:7241819
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccn2
cellular communication network factor 2
disease_progression
IEP
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Clu
clusterin
treatment
IEP
RGD
PMID:22494435
RGD:9068431
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cs
citrate synthase
treatment
IDA
RGD
PMID:20005400
RGD:243048470
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
treatment
IDA
RGD
PMID:18209025
RGD:9685339
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Pdgfa
platelet derived growth factor subunit A
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdgfb
platelet derived growth factor subunit B
IEP
mRNA:increased expression:kidney:
RGD
PMID:15785371 PMID:11889420
RGD:10449491 , RGD:11080974
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Plau
plasminogen activator, urokinase
ISO
protein:increased secretion:T lymphocyte (human)
RGD
PMID:16387096
RGD:7241259
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
protein:increased expression:kidney:
RGD
PMID:16221712
RGD:13208600
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Serpine1
serpin family E member 1
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:16221712 PMID:18192922
RGD:13208600 , RGD:13208601
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all